Fusion Pharmaceuticals Announces Second Quarter 2023 Financial Results and Clinical Program Updates ...Middle East

PR Newswire - News
Fusion Pharmaceuticals Announces Second Quarter 2023 Financial Results and Clinical Program Updates
FPI-2265 (Ac-PSMA I&T) IND transferred to Fusion; program is enrolling patients and on track for Q1 2024 update Preliminary clinical data presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) from the Phase 1 Trial of FPI-1434 showed the cold/hot dosing regimen...

Hence then, the article about fusion pharmaceuticals announces second quarter 2023 financial results and clinical program updates was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Fusion Pharmaceuticals Announces Second Quarter 2023 Financial Results and Clinical Program Updates )

Apple Storegoogle play

Last updated :

Also on site :